ArticleCancer gene therapy2006

Therapeutic effects of adoptive splenocyte transfer following in situ AdIL-12 gene therapy in a mouse prostate cancer model.

T Saika et al.PubMed ↗Publisher ↗

No numbers read from the abstract.